$377.79
$0.00 (0.00%)
End-of-day quote: 11/30/2022
NasdaqGS:ABMD
Abiomed Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | NYSE | Outperform | $102.19 | $125.59 | 0.00% | 7 | $177.77B |
| BSX | Boston Scientific | NYSE | Buy | $75.57 | $81.53 | 0.00% | 6 | $111.10B |
| MDT | Medtronic | NYSE | Outperform | $81.37 | $94.07 | 0.00% | 9 | $106.70B |
| EW | Edwards Lifesciences Corp | NYSE | Outperform | $86.89 | $96.55 | 0.00% | 5 | $52.36B |
| TFX | Teleflex Inc | NYSE | Hold | $209.07 | $263.46 | 0.00% | 2 | $9.64B |
| HAE | Haemonetics | NYSE | Outperform | $84.08 | $70.17 | 0.00% | 1 | $4.87B |
| MMSI | Merit Medical Systems | NasdaqGS | Outperform | $81.15 | $89.25 | 0.00% | 0 | $4.65B |
| ITGR | Integer Holdings | NYSE | Outperform | $121.24 | $95.00 | 0.00% | 0 | $3.83B |
| ICUI | ICU Medical | NasdaqGS | Outperform | $106.34 | $153.50 | 0.00% | 3 | $2.48B |
| CNMD | CONMED | NYSE | Outperform | $76.44 | $123.38 | 0.00% | 1 | $2.09B |
| IART | Integra LifeSciences Holdings | NasdaqGS | Hold | $30.90 | $46.60 | 0.00% | 4 | $1.82B |
| LMAT | LeMaitre Vascular | NasdaqGM | Outperform | $78.88 | $59.86 | 0.00% | 0 | $1.45B |
| NVRO | Nevro | NYSE | Hold | $9.35 | $21.34 | 0.00% | 1 | $422.94M |
| STXS | Stereotaxis | NYSEAM | Buy | $1.93 | $4.25 | 0.00% | 1 | $179.03M |
